Stockton, California/December 3, 2012/Newswire/ Viratech Corp. (OTC:VIRA) and Newswire are proud to announce that the first episode of  “This Week in Viratech” has been released. The episode can be viewed at http://www.youtube.com/watch?v=YsZk_FF2jtY&feature=youtu.be  and explains in depth the appointment of Dr. Kevin Buckman as the new CEO of Viratech, Corp, with a spotlight on his achievements including:

Kevin Buckman MD FAAIM, DAAUCM, MACOEM, MRO completed his Medical School training at USC; he remained at USC for internship and 2^nd year residency in Internal Medicine, and completed his training in Internal Medicine in 1981 at San Joaquin General Hospital, a UC Davis affiliate. He received Post Graduate Training at Stanford University School of Business, and attended seminars with the Securities Exchange Institute.  He began his research in 1977 in the field of immunology, cancer, diabetes, and chronic diseases. His discovery of the role of Inflammation and Abnormal Cellular Environment in Cancer and immune disease in the 70’s has made him a leader in the field.  His continuous research in this field has lead to his technologies in Non-Harmful Medicine with Early Diagnosis and Treatments, especially in the field of Women’s Health.  He has published books including Find and Stop Breast Cancer, and Find and Stop Diabetes. He was recently a Speaker and Exhibitor at the International Cancer Conference and Forum 2010, in Seoul, Korea, where he addressed many women’s health issues and solutions.

Dr. Buckman has served as Medical Director in various hospitals and institutions for over 25 years and has over 35 years of clinical experience. He has served as a member of the Executive Committee for six years at St. Dominic’s Hospital in Manteca, California.  He has written many patents for new medical technologies.  From 1986 to 1997 there were more than 50 Physicians  under his direction at various institutions and hospitals. He also served as Medical Director for Dameron Hospital EMS Liaison from 2002 to 2003.  He became Board Certified in Emergency Medicine and a Fellow of the American Board of Emergency Medicine in 1990.

Dr. Buckman has received numerous Certifications and specialty training in the field of Medicine. He is a Fellow in the American Association of Integrated Medicine, and a certified Medical Review Officer. His other specialties include: Internal Medicine, Forensic Medicine, Chinese Medicine and Acupuncture. He has over three decades of hospital and clinical experience and has served on over 15 hospital committees. He became Board Certified in Urgent Care Medicine and a Diplomate in 2006.

Dr. Buckman has presented research, published articles and books in the field of medicine, has exhibited breast cancer technologies, and given lectures at numerous hospitals and at International Medical Conferences, has exhibited Breast Cancer technologies.

Dr. Buckman serves on the Board of Directors for the California College of Natural Medicine.  He was the first U.S. physician to be accepted into the European Group for Breast Cancer Screening after his research in this field was accepted for publication and presentation at their international conference in Cyprus.  For many years he has worked internationally to advance a number of medical technologies.  He has had a special interest in non-harmful early detection of disease, with a primary focus on Breast Cancer and Diabetes, his research in the field preventive medicine, and his expertise in non-harmful new methods of medical treatment for cancer. His most recent Breast Cancer work was published at the International Cancer Conference and Forum 2010, in Seoul, Korea. He is currently serving on the Industry Advisory Board for the University of Pacific School of Engineering and Computer Science and a Visiting Professor in Bioengineering, University of Pacific School of Engineering and Computer Science. 

Dr. John Stein

Dr. Stein has been involved in numerous prospective and randomized trials of drug as well as technology implementations in the acute care environment. He received his Medical Degree  from Dartmouth Medical School where he was elected into the Syvertsen Scholarship, received the Merck Manual Award, and graduated in the Alpha Omega Alpha Medical Honors Society. He pursued clinical training at the Alameda County Medical Center's Highland Hospital, one of the most competitive residency training programs in Emergency Medicine.   Since that time he has been on the faculty at UCSF, and has assumed a number of roles aside from research including directing the Emergency Ultrasound Department, and acting as one of the medical school's eight Advisory College Mentors.

Dr. Stein has recently received a K-08 award from the Agency for Research and Quality which aimed to validate the training guidelines for emergency ultrasound as they pertain to the evaluation of ectopic pregnancy. As part of that four year grant, he completed his Masters in Clinical Research through the university's Clinical and Translational Sciences Institute, and he was also elected to the K Scholars group where he served from 2007-2011.

He has published manuscripts on over 20 prospective trials among a variety of other writings. He also has extensive background with industry and foundation partners, and has received grants from the California Healthcare Foundation as well as the Fujitsu Corporation.

Dr. Valerie Kidd

 Dr. Kidd’s work for many years in primary care allows her to understand the importance of early detection of disease and need to improve medical care, and access to care. Her teaching experience adds to her credibility in the realm of Primary Care and she is a valuable asset to Viratech’s Board of Directors. 

Dr. Kidd received her BA in Chemistry from UC Davis, College of Letters and Science in 1980.   She received her MD at University of California at Irvine, College of Medicine in1984.  She completed a Family Practice Residency Program at San Joaquin General Hospital from July 1984 to July 1987.   She became first Board Certificated in Family Practice in 1987, then again in 1993, 2000, and 2007.    Dr. Kidd is an active member of the American Academy of Family Physicians since 1987.   She has been practicing medicine at Lodi Memorial Hospital since 2006.   Since 2006, Dr. Kidd has held the following positions:

1987-1988, Staff Physician, Employee Health Services, San Joaquin General Hospital;

1988-1991, Staff Physician, Lincoln Family Medial Group, Douglas Road, Stockton;

1991-1995, Staff Physician, Employee Health Services, Modesto, Stanislaus County;

1995-1996, Physician, California State University Stanislaus Student Health Center;

1996-2006, Staff Physician, Employee Health Services Clinic, San Joaquin General Hospital;

2007-March 2009, Family Medicine Physician, St Joseph’s Medical Group of Stockton;

2007-March 2009, Medical Director, University of Pacific, Cowell Wellness Center Student Health;

2006-present, Staff Physician, Lodi Memorial Hospital Urgent Care Clinic;

2006-present, Staff Physician, Lodi Memorial Occupational Med Clinic;

Teaching Positions:

1988-2003, University of Pacific, Physical Therapy Guest Lecturer;

1987-1991, Clinical Preceptor, San Joaquin Family Practice Residency;

1991-1996, Clinic Preceptor, Stanislaus Family Practice Residency;

1996-2003, Clinic Preceptor, San Joaquin Family Practice Residency.

Dr. Aziz Kamali

 Dr. Kamali is the Founder of the Omar Kamali Medical Center in Afghanistan. This hospital is a new facility with 350 beds and plans for expansion to serve many more patients. It is part of AHERO, Afghanistan’s Health Education and Reconstruction Organization, which was founded by Dr. Kamali, and can be found on the web at www.aHero.org.

Dr. Kamali was born and raised in Jalalabad, in eastern Afghanistan. He obtained his secondary education in Kabul and did his undergraduate studies at the University of Afghanistan in Kabul.

Dr. Kamali comes from a large family of medical, legal and engineering professionals who have been very active with the current development of Afghanistan, following in the footsteps of their father, Mohammed Shirin Kamali, a judge in eastern Afghanistan.  Dr. Kamali is a diplomate of the American Board of Internal Medicine.

Dr. Kamali is an associate clinical professor at the University of California, Davis, School of Medicine, in Sacramento, California. He did his postgraduate training in England and has a full registration with the British General Medical Council. He is a Fellow of the American College of Physicians and an Associate Fellow of American College of Cardiology.

 “I am pleased to accept the appointment to Viratech’s Board of Directors,” said Dr. Kamali.  I look forward to the innovations in open source medical research that will bring medical technology into the 21^st Century,” he added.

Tutorial Videos

Tutorial videos were released, in order to assist our open source development partners. Viratech has released a 30 part tutorial based system to help accelerate the understanding our new toolset.  The videos appear at: http://viratech.org/s/pageitem/videointros.  Says Dr. Kevin Buckman, CEO and founder of Viratech, “The videos explain everything, from how to use the site, to the Company’s unique activity point system, to assist the user in protecting intellectual property, promoting open source research, and commercial development of new diagnostics and therapies.”

About Viratech Corp.

Based in Stockton, California, Viratech Corp. has created an open source biotech research and development platform, Viratech has created a unique platform leveraging the utility of social collaboration, which will allow cancer research the opportunity for the first time to become open sourced.  This is accomplished by allowing our development partners the ability to protect, promote and produce their research in unified online collaboration hubs known as micro social networks. Viratech’s open source platform has integrated several intellectual property tools which, by leveraging our social collaboration network, can give our development partners a new intellectual property mechanism, which will help in addressing the protection of Intellectual Property, promotion through collaboration in our protected open source platform, and commercial development of the products achieved through collaborative research.

Using this platform, Viratech members can protect their intellectual property, then use Viratech’s micro social network as a utility to promote and crowdfund the research and development to produce the new technology.

Forward-Looking Statements:

This press release includes forward-looking statements concerning the future performance of our business, its operations and its financial performance and condition, and also includes selected operating results presented without the context of accompanying financial results. These forward-looking statements include, among others, statements with respect to our objectives and strategies to achieve those objectives, as well as statements with respect to our beliefs, plans, expectations, anticipations, estimates or intentions. These forward-looking statements are based on our current expectations. We caution that all forward-looking information is inherently uncertain and actual results may differ materially from the assumptions, estimates or expectations reflected or contained in the forward-looking information, and that actual future performance will be affected by a number of factors, including economic conditions, technological change, regulatory change and competitive factors, many of which are beyond our control. Therefore, future events and results may vary significantly from what we currently foresee. We are under no obligation (and we expressly disclaim any such obligation) to update or alter the forward-looking statements whether as a result of new information, future events or otherwise.

Contact : Dr. Kevin Buckman, CEO

Viratech Corp.

http://www.viratech.org

Email Contact: info@viratech.org

Stockton, California/December 3, 2012/Newswire/ Viratech Corp. (OTC:VIRA) and Newswire are proud to announce that the first episode of  “This Week in Viratech” has been released. The episode can be viewed at http://www.youtube.com/watch?v=YsZk_FF2jtY&feature=youtu.be  and explains in depth the appointment of Dr. Kevin Buckman as the new CEO of Viratech, Corp, with a spotlight on his achievements including:

Kevin Buckman MD FAAIM, DAAUCM, MACOEM, MRO completed his Medical School training at USC; he remained at USC for internship and 2^nd year residency in Internal Medicine, and completed his training in Internal Medicine in 1981 at San Joaquin General Hospital, a UC Davis affiliate. He received Post Graduate Training at Stanford University School of Business, and attended seminars with the Securities Exchange Institute.  He began his research in 1977 in the field of immunology, cancer, diabetes, and chronic diseases. His discovery of the role of Inflammation and Abnormal Cellular Environment in Cancer and immune disease in the 70’s has made him a leader in the field.  His continuous research in this field has lead to his technologies in Non-Harmful Medicine with Early Diagnosis and Treatments, especially in the field of Women’s Health.  He has published books including Find and Stop Breast Cancer, and Find and Stop Diabetes. He was recently a Speaker and Exhibitor at the International Cancer Conference and Forum 2010, in Seoul, Korea, where he addressed many women’s health issues and solutions.

Dr. Buckman has served as Medical Director in various hospitals and institutions for over 25 years and has over 35 years of clinical experience. He has served as a member of the Executive Committee for six years at St. Dominic’s Hospital in Manteca, California.  He has written many patents for new medical technologies.  From 1986 to 1997 there were more than 50 Physicians  under his direction at various institutions and hospitals. He also served as Medical Director for Dameron Hospital EMS Liaison from 2002 to 2003.  He became Board Certified in Emergency Medicine and a Fellow of the American Board of Emergency Medicine in 1990.

Dr. Buckman has received numerous Certifications and specialty training in the field of Medicine. He is a Fellow in the American Association of Integrated Medicine, and a certified Medical Review Officer. His other specialties include: Internal Medicine, Forensic Medicine, Chinese Medicine and Acupuncture. He has over three decades of hospital and clinical experience and has served on over 15 hospital committees. He became Board Certified in Urgent Care Medicine and a Diplomate in 2006.

Dr. Buckman has presented research, published articles and books in the field of medicine, has exhibited breast cancer technologies, and given lectures at numerous hospitals and at International Medical Conferences, has exhibited Breast Cancer technologies.

Dr. Buckman serves on the Board of Directors for the California College of Natural Medicine.  He was the first U.S. physician to be accepted into the European Group for Breast Cancer Screening after his research in this field was accepted for publication and presentation at their international conference in Cyprus.  For many years he has worked internationally to advance a number of medical technologies.  He has had a special interest in non-harmful early detection of disease, with a primary focus on Breast Cancer and Diabetes, his research in the field preventive medicine, and his expertise in non-harmful new methods of medical treatment for cancer. His most recent Breast Cancer work was published at the International Cancer Conference and Forum 2010, in Seoul, Korea. He is currently serving on the Industry Advisory Board for the University of Pacific School of Engineering and Computer Science and a Visiting Professor in Bioengineering, University of Pacific School of Engineering and Computer Science. 

Dr. John Stein

Dr. Stein has been involved in numerous prospective and randomized trials of drug as well as technology implementations in the acute care environment. He received his Medical Degree  from Dartmouth Medical School where he was elected into the Syvertsen Scholarship, received the Merck Manual Award, and graduated in the Alpha Omega Alpha Medical Honors Society. He pursued clinical training at the Alameda County Medical Center's Highland Hospital, one of the most competitive residency training programs in Emergency Medicine.   Since that time he has been on the faculty at UCSF, and has assumed a number of roles aside from research including directing the Emergency Ultrasound Department, and acting as one of the medical school's eight Advisory College Mentors.

Dr. Stein has recently received a K-08 award from the Agency for Research and Quality which aimed to validate the training guidelines for emergency ultrasound as they pertain to the evaluation of ectopic pregnancy. As part of that four year grant, he completed his Masters in Clinical Research through the university's Clinical and Translational Sciences Institute, and he was also elected to the K Scholars group where he served from 2007-2011.

He has published manuscripts on over 20 prospective trials among a variety of other writings. He also has extensive background with industry and foundation partners, and has received grants from the California Healthcare Foundation as well as the Fujitsu Corporation.

Dr. Valerie Kidd

 Dr. Kidd’s work for many years in primary care allows her to understand the importance of early detection of disease and need to improve medical care, and access to care. Her teaching experience adds to her credibility in the realm of Primary Care and she is a valuable asset to Viratech’s Board of Directors. 

Dr. Kidd received her BA in Chemistry from UC Davis, College of Letters and Science in 1980.   She received her MD at University of California at Irvine, College of Medicine in1984.  She completed a Family Practice Residency Program at San Joaquin General Hospital from July 1984 to July 1987.   She became first Board Certificated in Family Practice in 1987, then again in 1993, 2000, and 2007.    Dr. Kidd is an active member of the American Academy of Family Physicians since 1987.   She has been practicing medicine at Lodi Memorial Hospital since 2006.   Since 2006, Dr. Kidd has held the following positions:

1987-1988, Staff Physician, Employee Health Services, San Joaquin General Hospital;

1988-1991, Staff Physician, Lincoln Family Medial Group, Douglas Road, Stockton;

1991-1995, Staff Physician, Employee Health Services, Modesto, Stanislaus County;

1995-1996, Physician, California State University Stanislaus Student Health Center;

1996-2006, Staff Physician, Employee Health Services Clinic, San Joaquin General Hospital;

2007-March 2009, Family Medicine Physician, St Joseph’s Medical Group of Stockton;

2007-March 2009, Medical Director, University of Pacific, Cowell Wellness Center Student Health;

2006-present, Staff Physician, Lodi Memorial Hospital Urgent Care Clinic;

2006-present, Staff Physician, Lodi Memorial Occupational Med Clinic;

Teaching Positions:

1988-2003, University of Pacific, Physical Therapy Guest Lecturer;

1987-1991, Clinical Preceptor, San Joaquin Family Practice Residency;

1991-1996, Clinic Preceptor, Stanislaus Family Practice Residency;

1996-2003, Clinic Preceptor, San Joaquin Family Practice Residency.

Dr. Aziz Kamali

 Dr. Kamali is the Founder of the Omar Kamali Medical Center in Afghanistan. This hospital is a new facility with 350 beds and plans for expansion to serve many more patients. It is part of AHERO, Afghanistan’s Health Education and Reconstruction Organization, which was founded by Dr. Kamali, and can be found on the web at www.aHero.org.

Dr. Kamali was born and raised in Jalalabad, in eastern Afghanistan. He obtained his secondary education in Kabul and did his undergraduate studies at the University of Afghanistan in Kabul.

Dr. Kamali comes from a large family of medical, legal and engineering professionals who have been very active with the current development of Afghanistan, following in the footsteps of their father, Mohammed Shirin Kamali, a judge in eastern Afghanistan.  Dr. Kamali is a diplomate of the American Board of Internal Medicine.

Dr. Kamali is an associate clinical professor at the University of California, Davis, School of Medicine, in Sacramento, California. He did his postgraduate training in England and has a full registration with the British General Medical Council. He is a Fellow of the American College of Physicians and an Associate Fellow of American College of Cardiology.

 “I am pleased to accept the appointment to Viratech’s Board of Directors,” said Dr. Kamali.  I look forward to the innovations in open source medical research that will bring medical technology into the 21^st Century,” he added.

Tutorial Videos

Tutorial videos were released, in order to assist our open source development partners. Viratech has released a 30 part tutorial based system to help accelerate the understanding our new toolset.  The videos appear at: http://viratech.org/s/pageitem/videointros.  Says Dr. Kevin Buckman, CEO and founder of Viratech, “The videos explain everything, from how to use the site, to the Company’s unique activity point system, to assist the user in protecting intellectual property, promoting open source research, and commercial development of new diagnostics and therapies.”

About Viratech Corp.

Based in Stockton, California, Viratech Corp. has created an open source biotech research and development platform, Viratech has created a unique platform leveraging the utility of social collaboration, which will allow cancer research the opportunity for the first time to become open sourced.  This is accomplished by allowing our development partners the ability to protect, promote and produce their research in unified online collaboration hubs known as micro social networks. Viratech’s open source platform has integrated several intellectual property tools which, by leveraging our social collaboration network, can give our development partners a new intellectual property mechanism, which will help in addressing the protection of Intellectual Property, promotion through collaboration in our protected open source platform, and commercial development of the products achieved through collaborative research.

Using this platform, Viratech members can protect their intellectual property, then use Viratech’s micro social network as a utility to promote and crowdfund the research and development to produce the new technology.

Forward-Looking Statements:

This press release includes forward-looking statements concerning the future performance of our business, its operations and its financial performance and condition, and also includes selected operating results presented without the context of accompanying financial results. These forward-looking statements include, among others, statements with respect to our objectives and strategies to achieve those objectives, as well as statements with respect to our beliefs, plans, expectations, anticipations, estimates or intentions. These forward-looking statements are based on our current expectations. We caution that all forward-looking information is inherently uncertain and actual results may differ materially from the assumptions, estimates or expectations reflected or contained in the forward-looking information, and that actual future performance will be affected by a number of factors, including economic conditions, technological change, regulatory change and competitive factors, many of which are beyond our control. Therefore, future events and results may vary significantly from what we currently foresee. We are under no obligation (and we expressly disclaim any such obligation) to update or alter the forward-looking statements whether as a result of new information, future events or otherwise.

Contact : Dr. Kevin Buckman, CEO

Viratech Corp.

http://www.viratech.org

Email Contact: info@viratech.org

STOCKTON, CALIFORNIA/December 3, 2012 / Newswire/ -- Viratech Corp. (OTC: VIRA), the first open source biotech research social network platform, announced today the appointment of Dr. Theresa Dale, Ph.D., DNS, C.C.N., N.P. to its Advisory Board.   Dr. Dale is a Certified Clinical Nutritionist, Traditional Naturopathic Practitioner, BioEnergetic Medical Consultant, Dean & Founder, California College of Natural Medicine, and President of the Wellness Center in the US.  

Since Europe is well known as the leader in medical research and education in the area of Naturopathy, Bio-Energetics, Magnetic Fields and Homeopathy, Dr. Dale chose to fulfill her Naturopathic Studies in U.S.A. and Europe. The residential training awarded her a Naturopathic Doctor and a Doctor of Naturopathic Science degree (1988) at Clayton University, St. Louis, Mo. Clayton University's prestigious Board of Directors included pioneers and experts such as Linus Pauling, and many other noted authorities. She chose Clayton University so that she could learn "true" Naturopathy, which does not and never has included the use of drugs or surgery.

Dr. Dale has been in private practice since 1980 in the areas of homeopathy, naturopathy, nutrition, magnetic field therapy, and emotional release technologies. In 1994 she founded the California College of Natural Medicine, a California state-approved college, which offers advanced Naturopathic training to health professionals. Dr. Dale is a medical consultant to health providers and is a instructor and Dean at CCNM.

Dr. Dale's interest in non-invasive therapies expanded when she was diagnosed with a uterine tumor at 22 years of age. After healing herself using natural methods, she decided to dedicate her life to helping others to do the same.

Dr. Dale invented and formulated a naturopathic approach to balancing hormones, which incorporates her own 24-hour circadian rhythm saliva test, endocrine rebuilding diet, homeopathy and meridian balancing. The "NuFem Hormone Rejuvenation System" is an advanced system of endocrine healing and rebuilding incorporating NuFem transdermal creams which is a new homeopathic delivery system. In addition, Dr. Dale is the inventor of the professional healing technology, NeuroPhysical Reprogramming®, which is now state-approved in California and a part of the curriculum at The International College of Naturopathy.

Dr. Dale saw the need for patients to deeply heal their body by releasing core emotional issues causing disease, therefore, she invented Neuro-Emotional Remedies® in 1990, The Meta-Wellness Home Study Program in 1994 and two music therapy Compact Discs; Synchrony and 5 Element Healing in 1996.

Among the curriculum she has written is the first "Homeopathic Endocrinology" Training. Dr. Dale has authored the "Biotic Mac Slow Foods Cookbook" and most recently, "Transform Your Emotional DNA, Understanding the Blueprint of Your Life." In addition, she has been on the cutting edge in her field, recognizing the crucial connection between resisted emotions and physical illness. A new book is in the process on hormone rejuvenation, which will give self-help methods based on results from thousands of individuals who have healed their endocrine system using homeopathy and Theresa Dale's anti-aging lifestyle.

Dr. Dale is a frequent guest on radio shows and over the past two decades has been featured on The Leeza Show, NBC News, Vogue, EXTRA, and Homeopathy Today. Dr. Dale is the founder of the Wellness Center for Research & Education, Inc., BioResonance Research and the California College of Natural Medicine. a state-approved institution where she serves as Dean.  Dr. Dale has been an international speaker in her areas of expertise, including Germany, England, and the U.S.  She is an expert in Homeopathy, a State-Approved Instructor, a Traditional Naturopath, a Certified Clinical Nutritionist, a Doctor of Naturopathic Sciences, a Medical Consultant, and an Inventor. She has been interviewed on National TV with Leeza Gibbons,  Caryl & Marilyn, Hard Copy, E-Extra, and Alive & Wellness. She is host of her own cable television talk show for the past decade called Health Network.

 “I share Viratech’s vision of improved medical care and to even the playing field for the introduction of new and innovative treatment programs using open sourced research,” said Dr. Dale.  “I am looking forward to working with Dr. Buckman and the impressive group of medical professionals that he has put together to accomplish this vision,” said Dr. Dale.

About Viratech Corp.

Based in Stockton, California, Viratech Corp. has created an open source biotech research and development platform, Viratech has created a unique platform leveraging the utility of social collaboration, which will allow cancer research the opportunity for the first time to become open sourced.  This is accomplished by allowing our development partners the ability to protect, promote and produce their research in unified online collaboration hubs known as micro social networks. Viratech’s open source platform has integrated several intellectual property tools which, by leveraging our social collaboration network, can give our development partners a new intellectual property mechanism, which will help in addressing the protection of Intellectual Property, promotion through collaboration in our protected open source platform, and commercial development of the products achieved through collaborative research.

Using this platform, Viratech members can protect their intellectual property, then use Viratech’s micro social network as a utility to promote and crowdfund the research and development to produce the new technology.

Forward-Looking Statements:

This press release includes forward-looking statements concerning the future performance of our business, its operations and its financial performance and condition, and also includes selected operating results presented without the context of accompanying financial results. These forward-looking statements include, among others, statements with respect to our objectives and strategies to achieve those objectives, as well as statements with respect to our beliefs, plans, expectations, anticipations, estimates or intentions. These forward-looking statements are based on our current expectations. We caution that all forward-looking information is inherently uncertain and actual results may differ materially from the assumptions, estimates or expectations reflected or contained in the forward-looking information, and that actual future performance will be affected by a number of factors, including economic conditions, technological change, regulatory change and competitive factors, many of which are beyond our control. Therefore, future events and results may vary significantly from what we currently foresee. We are under no obligation (and we expressly disclaim any such obligation) to update or alter the forward-looking statements whether as a result of new information, future events or otherwise.

Contact : Dr. Kevin Buckman, CMO/Director

Viratech Corp.

http://viratech.org

Email Contact: info@viratech.org

STOCKTON, CALIFORNIA/December 3, 2012 /Newswire/ -- Viratech, Inc. (OTC: VIRA), the first open source biotech research social network platform, announced today the appointment of Jared Greenholz ,MD FACEP FAAEM to its Advisory Committee.  Dr Greenholz obtained his doctorate of medicine from New York Medical College in 1996 and completed his residency in Emergency Medicine at Alameda County Medical Center in 2000. He has focused his professional efforts on providing exceptional clinical emergency care in high volume tertiary care hospitals in Nevada and California.

Dr. Greenholz has taken an active role in teaching emergency medicine and internal medicine residents. His calming, focused, teaching style has enabled countless developing physicians to acquire the confidence, skill, and knowledge that is needed to become a capable, efficient emergency physician. His professional areas of expertise include advanced airway management, ultrasound, and emergency cardiac care.

Dr. Greenholz has served as QA Director for a large emergency medicine group that provides coverage for multiple high volume departments. This role afforded him the opportunity to review cases where there was a concern about the quality of care provided. He has also served as Medical Director for Storey County Fire Department for the last decade, in a supervisory role where he would review EMS policy, guide care delivered, and provide clinical teaching for a moderate volume, suburban county EMS system.

Dr. Greenholz is a Fellow in both the American College of Emergency Physicians and the American Academy of Emergency Physicians and is an active participant in both organizations.  He has been working as an expert peer reviewer for the Medical Boards of both California and Nevada. This role allows him to review cases in emergency medicine where there some aspect of the care delivered has been questioned. He reviews the entire case and renders an expert opinion about whether there has been any deviation from the standard of care.

“I am happy to join Dr. Buckman as a part of Viratech and look forward to the Company’s advances in the field of medical research and protection of innovative treatment ideas,” said Dr. Greenholz.

About Viratech Corp.

Based in Stockton, California, Viratech Corp. has created an open source biotech research and development platform, Viratech has created a unique platform leveraging the utility of social collaboration, which will allow cancer research the opportunity for the first time to become open sourced.  This is accomplished by allowing our development partners the ability to protect, promote and produce their research in unified online collaboration hubs known as micro social networks. Viratech’s open source platform has integrated several intellectual property tools which, by leveraging our social collaboration network, can give our development partners a new intellectual property mechanism, which will help in addressing the protection of Intellectual Property, promotion through collaboration in our protected open source platform, and commercial development of the products achieved through collaborative research.

Using this platform, Viratech members can protect their intellectual property, then use Viratech’s micro social network as a utility to promote and crowdfund the research and development to produce the new technology.

Forward-Looking Statements:

This press release includes forward-looking statements concerning the future performance of our business, its operations and its financial performance and condition, and also includes selected operating results presented without the context of accompanying financial results. These forward-looking statements include, among others, statements with respect to our objectives and strategies to achieve those objectives, as well as statements with respect to our beliefs, plans, expectations, anticipations, estimates or intentions. These forward-looking statements are based on our current expectations. We caution that all forward-looking information is inherently uncertain and actual results may differ materially from the assumptions, estimates or expectations reflected or contained in the forward-looking information, and that actual future performance will be affected by a number of factors, including economic conditions, technological change, regulatory change and competitive factors, many of which are beyond our control. Therefore, future events and results may vary significantly from what we currently foresee. We are under no obligation (and we expressly disclaim any such obligation) to update or alter the forward-looking statements whether as a result of new information, future events or otherwise.

Contact : Dr. Kevin Buckman, CEO/Director

Viratech Corp.

http://viratech.org

Email Contact: info@viratech.org

Stockton, California/December 3, 2012/Newswire/ Viratech Corp. (OTC:VIRA) and Newswire are proud to announce that the first episode of  “This Week in Viratech” has been released. The episode can be viewed at http://www.youtube.com/watch?v=YsZk_FF2jtY&feature=youtu.be  and explains in depth the appointment of Dr. Kevin Buckman as the new CEO of Viratech, Corp, with a spotlight on his achievements including:

Kevin Buckman MD FAAIM, DAAUCM, MACOEM, MRO completed his Medical School training at USC; he remained at USC for internship and 2^nd year residency in Internal Medicine, and completed his training in Internal Medicine in 1981 at San Joaquin General Hospital, a UC Davis affiliate. He received Post Graduate Training at Stanford University School of Business, and attended seminars with the Securities Exchange Institute.  He began his research in 1977 in the field of immunology, cancer, diabetes, and chronic diseases. His discovery of the role of Inflammation and Abnormal Cellular Environment in Cancer and immune disease in the 70’s has made him a leader in the field.  His continuous research in this field has lead to his technologies in Non-Harmful Medicine with Early Diagnosis and Treatments, especially in the field of Women’s Health.  He has published books including Find and Stop Breast Cancer, and Find and Stop Diabetes. He was recently a Speaker and Exhibitor at the International Cancer Conference and Forum 2010, in Seoul, Korea, where he addressed many women’s health issues and solutions.

Dr. Buckman has served as Medical Director in various hospitals and institutions for over 25 years and has over 35 years of clinical experience. He has served as a member of the Executive Committee for six years at St. Dominic’s Hospital in Manteca, California.  He has written many patents for new medical technologies.  From 1986 to 1997 there were more than 50 Physicians  under his direction at various institutions and hospitals. He also served as Medical Director for Dameron Hospital EMS Liaison from 2002 to 2003.  He became Board Certified in Emergency Medicine and a Fellow of the American Board of Emergency Medicine in 1990.

Dr. Buckman has received numerous Certifications and specialty training in the field of Medicine. He is a Fellow in the American Association of Integrated Medicine, and a certified Medical Review Officer. His other specialties include: Internal Medicine, Forensic Medicine, Chinese Medicine and Acupuncture. He has over three decades of hospital and clinical experience and has served on over 15 hospital committees. He became Board Certified in Urgent Care Medicine and a Diplomate in 2006.

Dr. Buckman has presented research, published articles and books in the field of medicine, has exhibited breast cancer technologies, and given lectures at numerous hospitals and at International Medical Conferences, has exhibited Breast Cancer technologies.

Dr. Buckman serves on the Board of Directors for the California College of Natural Medicine.  He was the first U.S. physician to be accepted into the European Group for Breast Cancer Screening after his research in this field was accepted for publication and presentation at their international conference in Cyprus.  For many years he has worked internationally to advance a number of medical technologies.  He has had a special interest in non-harmful early detection of disease, with a primary focus on Breast Cancer and Diabetes, his research in the field preventive medicine, and his expertise in non-harmful new methods of medical treatment for cancer. His most recent Breast Cancer work was published at the International Cancer Conference and Forum 2010, in Seoul, Korea. He is currently serving on the Industry Advisory Board for the University of Pacific School of Engineering and Computer Science and a Visiting Professor in Bioengineering, University of Pacific School of Engineering and Computer Science. 

Dr. John Stein

Dr. Stein has been involved in numerous prospective and randomized trials of drug as well as technology implementations in the acute care environment. He received his Medical Degree  from Dartmouth Medical School where he was elected into the Syvertsen Scholarship, received the Merck Manual Award, and graduated in the Alpha Omega Alpha Medical Honors Society. He pursued clinical training at the Alameda County Medical Center's Highland Hospital, one of the most competitive residency training programs in Emergency Medicine.   Since that time he has been on the faculty at UCSF, and has assumed a number of roles aside from research including directing the Emergency Ultrasound Department, and acting as one of the medical school's eight Advisory College Mentors.

Dr. Stein has recently received a K-08 award from the Agency for Research and Quality which aimed to validate the training guidelines for emergency ultrasound as they pertain to the evaluation of ectopic pregnancy. As part of that four year grant, he completed his Masters in Clinical Research through the university's Clinical and Translational Sciences Institute, and he was also elected to the K Scholars group where he served from 2007-2011.

He has published manuscripts on over 20 prospective trials among a variety of other writings. He also has extensive background with industry and foundation partners, and has received grants from the California Healthcare Foundation as well as the Fujitsu Corporation.

Dr. Valerie Kidd

 Dr. Kidd’s work for many years in primary care allows her to understand the importance of early detection of disease and need to improve medical care, and access to care. Her teaching experience adds to her credibility in the realm of Primary Care and she is a valuable asset to Viratech’s Board of Directors. 

Dr. Kidd received her BA in Chemistry from UC Davis, College of Letters and Science in 1980.   She received her MD at University of California at Irvine, College of Medicine in1984.  She completed a Family Practice Residency Program at San Joaquin General Hospital from July 1984 to July 1987.   She became first Board Certificated in Family Practice in 1987, then again in 1993, 2000, and 2007.    Dr. Kidd is an active member of the American Academy of Family Physicians since 1987.   She has been practicing medicine at Lodi Memorial Hospital since 2006.   Since 2006, Dr. Kidd has held the following positions:

1987-1988, Staff Physician, Employee Health Services, San Joaquin General Hospital;

1988-1991, Staff Physician, Lincoln Family Medial Group, Douglas Road, Stockton;

1991-1995, Staff Physician, Employee Health Services, Modesto, Stanislaus County;

1995-1996, Physician, California State University Stanislaus Student Health Center;

1996-2006, Staff Physician, Employee Health Services Clinic, San Joaquin General Hospital;

2007-March 2009, Family Medicine Physician, St Joseph’s Medical Group of Stockton;

2007-March 2009, Medical Director, University of Pacific, Cowell Wellness Center Student Health;

2006-present, Staff Physician, Lodi Memorial Hospital Urgent Care Clinic;

2006-present, Staff Physician, Lodi Memorial Occupational Med Clinic;

Teaching Positions:

1988-2003, University of Pacific, Physical Therapy Guest Lecturer;

1987-1991, Clinical Preceptor, San Joaquin Family Practice Residency;

1991-1996, Clinic Preceptor, Stanislaus Family Practice Residency;

1996-2003, Clinic Preceptor, San Joaquin Family Practice Residency.

Dr. Aziz Kamali

 Dr. Kamali is the Founder of the Omar Kamali Medical Center in Afghanistan. This hospital is a new facility with 350 beds and plans for expansion to serve many more patients. It is part of AHERO, Afghanistan’s Health Education and Reconstruction Organization, which was founded by Dr. Kamali, and can be found on the web at www.aHero.org.

Dr. Kamali was born and raised in Jalalabad, in eastern Afghanistan. He obtained his secondary education in Kabul and did his undergraduate studies at the University of Afghanistan in Kabul.

Dr. Kamali comes from a large family of medical, legal and engineering professionals who have been very active with the current development of Afghanistan, following in the footsteps of their father, Mohammed Shirin Kamali, a judge in eastern Afghanistan.  Dr. Kamali is a diplomate of the American Board of Internal Medicine.

Dr. Kamali is an associate clinical professor at the University of California, Davis, School of Medicine, in Sacramento, California. He did his postgraduate training in England and has a full registration with the British General Medical Council. He is a Fellow of the American College of Physicians and an Associate Fellow of American College of Cardiology.

 “I am pleased to accept the appointment to Viratech’s Board of Directors,” said Dr. Kamali.  I look forward to the innovations in open source medical research that will bring medical technology into the 21^st Century,” he added.

Tutorial Videos

Tutorial videos were released, in order to assist our open source development partners. Viratech has released a 30 part tutorial based system to help accelerate the understanding our new toolset.  The videos appear at: http://viratech.org/s/pageitem/videointros.  Says Dr. Kevin Buckman, CEO and founder of Viratech, “The videos explain everything, from how to use the site, to the Company’s unique activity point system, to assist the user in protecting intellectual property, promoting open source research, and commercial development of new diagnostics and therapies.”

About Viratech Corp.

Based in Stockton, California, Viratech Corp. has created an open source biotech research and development platform, Viratech has created a unique platform leveraging the utility of social collaboration, which will allow cancer research the opportunity for the first time to become open sourced.  This is accomplished by allowing our development partners the ability to protect, promote and produce their research in unified online collaboration hubs known as micro social networks. Viratech’s open source platform has integrated several intellectual property tools which, by leveraging our social collaboration network, can give our development partners a new intellectual property mechanism, which will help in addressing the protection of Intellectual Property, promotion through collaboration in our protected open source platform, and commercial development of the products achieved through collaborative research.

Using this platform, Viratech members can protect their intellectual property, then use Viratech’s micro social network as a utility to promote and crowdfund the research and development to produce the new technology.

Forward-Looking Statements:

This press release includes forward-looking statements concerning the future performance of our business, its operations and its financial performance and condition, and also includes selected operating results presented without the context of accompanying financial results. These forward-looking statements include, among others, statements with respect to our objectives and strategies to achieve those objectives, as well as statements with respect to our beliefs, plans, expectations, anticipations, estimates or intentions. These forward-looking statements are based on our current expectations. We caution that all forward-looking information is inherently uncertain and actual results may differ materially from the assumptions, estimates or expectations reflected or contained in the forward-looking information, and that actual future performance will be affected by a number of factors, including economic conditions, technological change, regulatory change and competitive factors, many of which are beyond our control. Therefore, future events and results may vary significantly from what we currently foresee. We are under no obligation (and we expressly disclaim any such obligation) to update or alter the forward-looking statements whether as a result of new information, future events or otherwise.

Contact : Dr. Kevin Buckman, CEO

Viratech Corp.

http://www.viratech.org

Email Contact: info@viratech.org

Stockton, California/December 3, 2012/Newswire/ Viratech Corp. (OTC:VIRA) and Newswire are proud to announce that the first episode of  “This Week in Viratech” has been released. The episode can be viewed at http://www.youtube.com/watch?v=YsZk_FF2jtY&feature=youtu.be  and explains in depth the appointment of Dr. Kevin Buckman as the new CEO of Viratech, Corp, with a spotlight on his achievements including:

Kevin Buckman MD FAAIM, DAAUCM, MACOEM, MRO completed his Medical School training at USC; he remained at USC for internship and 2^nd year residency in Internal Medicine, and completed his training in Internal Medicine in 1981 at San Joaquin General Hospital, a UC Davis affiliate. He received Post Graduate Training at Stanford University School of Business, and attended seminars with the Securities Exchange Institute.  He began his research in 1977 in the field of immunology, cancer, diabetes, and chronic diseases. His discovery of the role of Inflammation and Abnormal Cellular Environment in Cancer and immune disease in the 70’s has made him a leader in the field.  His continuous research in this field has lead to his technologies in Non-Harmful Medicine with Early Diagnosis and Treatments, especially in the field of Women’s Health.  He has published books including Find and Stop Breast Cancer, and Find and Stop Diabetes. He was recently a Speaker and Exhibitor at the International Cancer Conference and Forum 2010, in Seoul, Korea, where he addressed many women’s health issues and solutions.

Dr. Buckman has served as Medical Director in various hospitals and institutions for over 25 years and has over 35 years of clinical experience. He has served as a member of the Executive Committee for six years at St. Dominic’s Hospital in Manteca, California.  He has written many patents for new medical technologies.  From 1986 to 1997 there were more than 50 Physicians  under his direction at various institutions and hospitals. He also served as Medical Director for Dameron Hospital EMS Liaison from 2002 to 2003.  He became Board Certified in Emergency Medicine and a Fellow of the American Board of Emergency Medicine in 1990.

Dr. Buckman has received numerous Certifications and specialty training in the field of Medicine. He is a Fellow in the American Association of Integrated Medicine, and a certified Medical Review Officer. His other specialties include: Internal Medicine, Forensic Medicine, Chinese Medicine and Acupuncture. He has over three decades of hospital and clinical experience and has served on over 15 hospital committees. He became Board Certified in Urgent Care Medicine and a Diplomate in 2006.

Dr. Buckman has presented research, published articles and books in the field of medicine, has exhibited breast cancer technologies, and given lectures at numerous hospitals and at International Medical Conferences, has exhibited Breast Cancer technologies.

Dr. Buckman serves on the Board of Directors for the California College of Natural Medicine.  He was the first U.S. physician to be accepted into the European Group for Breast Cancer Screening after his research in this field was accepted for publication and presentation at their international conference in Cyprus.  For many years he has worked internationally to advance a number of medical technologies.  He has had a special interest in non-harmful early detection of disease, with a primary focus on Breast Cancer and Diabetes, his research in the field preventive medicine, and his expertise in non-harmful new methods of medical treatment for cancer. His most recent Breast Cancer work was published at the International Cancer Conference and Forum 2010, in Seoul, Korea. He is currently serving on the Industry Advisory Board for the University of Pacific School of Engineering and Computer Science and a Visiting Professor in Bioengineering, University of Pacific School of Engineering and Computer Science. 

Dr. John Stein

Dr. Stein has been involved in numerous prospective and randomized trials of drug as well as technology implementations in the acute care environment. He received his Medical Degree  from Dartmouth Medical School where he was elected into the Syvertsen Scholarship, received the Merck Manual Award, and graduated in the Alpha Omega Alpha Medical Honors Society. He pursued clinical training at the Alameda County Medical Center's Highland Hospital, one of the most competitive residency training programs in Emergency Medicine.   Since that time he has been on the faculty at UCSF, and has assumed a number of roles aside from research including directing the Emergency Ultrasound Department, and acting as one of the medical school's eight Advisory College Mentors.

Dr. Stein has recently received a K-08 award from the Agency for Research and Quality which aimed to validate the training guidelines for emergency ultrasound as they pertain to the evaluation of ectopic pregnancy. As part of that four year grant, he completed his Masters in Clinical Research through the university's Clinical and Translational Sciences Institute, and he was also elected to the K Scholars group where he served from 2007-2011.

He has published manuscripts on over 20 prospective trials among a variety of other writings. He also has extensive background with industry and foundation partners, and has received grants from the California Healthcare Foundation as well as the Fujitsu Corporation.

Dr. Valerie Kidd

 Dr. Kidd’s work for many years in primary care allows her to understand the importance of early detection of disease and need to improve medical care, and access to care. Her teaching experience adds to her credibility in the realm of Primary Care and she is a valuable asset to Viratech’s Board of Directors. 

Dr. Kidd received her BA in Chemistry from UC Davis, College of Letters and Science in 1980.   She received her MD at University of California at Irvine, College of Medicine in1984.  She completed a Family Practice Residency Program at San Joaquin General Hospital from July 1984 to July 1987.   She became first Board Certificated in Family Practice in 1987, then again in 1993, 2000, and 2007.    Dr. Kidd is an active member of the American Academy of Family Physicians since 1987.   She has been practicing medicine at Lodi Memorial Hospital since 2006.   Since 2006, Dr. Kidd has held the following positions:

1987-1988, Staff Physician, Employee Health Services, San Joaquin General Hospital;

1988-1991, Staff Physician, Lincoln Family Medial Group, Douglas Road, Stockton;

1991-1995, Staff Physician, Employee Health Services, Modesto, Stanislaus County;

1995-1996, Physician, California State University Stanislaus Student Health Center;

1996-2006, Staff Physician, Employee Health Services Clinic, San Joaquin General Hospital;

2007-March 2009, Family Medicine Physician, St Joseph’s Medical Group of Stockton;

2007-March 2009, Medical Director, University of Pacific, Cowell Wellness Center Student Health;

2006-present, Staff Physician, Lodi Memorial Hospital Urgent Care Clinic;

2006-present, Staff Physician, Lodi Memorial Occupational Med Clinic;

Teaching Positions:

1988-2003, University of Pacific, Physical Therapy Guest Lecturer;

1987-1991, Clinical Preceptor, San Joaquin Family Practice Residency;

1991-1996, Clinic Preceptor, Stanislaus Family Practice Residency;

1996-2003, Clinic Preceptor, San Joaquin Family Practice Residency.

Dr. Aziz Kamali

 Dr. Kamali is the Founder of the Omar Kamali Medical Center in Afghanistan. This hospital is a new facility with 350 beds and plans for expansion to serve many more patients. It is part of AHERO, Afghanistan’s Health Education and Reconstruction Organization, which was founded by Dr. Kamali, and can be found on the web at www.aHero.org.

Dr. Kamali was born and raised in Jalalabad, in eastern Afghanistan. He obtained his secondary education in Kabul and did his undergraduate studies at the University of Afghanistan in Kabul.

Dr. Kamali comes from a large family of medical, legal and engineering professionals who have been very active with the current development of Afghanistan, following in the footsteps of their father, Mohammed Shirin Kamali, a judge in eastern Afghanistan.  Dr. Kamali is a diplomate of the American Board of Internal Medicine.

Dr. Kamali is an associate clinical professor at the University of California, Davis, School of Medicine, in Sacramento, California. He did his postgraduate training in England and has a full registration with the British General Medical Council. He is a Fellow of the American College of Physicians and an Associate Fellow of American College of Cardiology.

 “I am pleased to accept the appointment to Viratech’s Board of Directors,” said Dr. Kamali.  I look forward to the innovations in open source medical research that will bring medical technology into the 21^st Century,” he added.

Tutorial Videos

Tutorial videos were released, in order to assist our open source development partners. Viratech has released a 30 part tutorial based system to help accelerate the understanding our new toolset.  The videos appear at: http://viratech.org/s/pageitem/videointros.  Says Dr. Kevin Buckman, CEO and founder of Viratech, “The videos explain everything, from how to use the site, to the Company’s unique activity point system, to assist the user in protecting intellectual property, promoting open source research, and commercial development of new diagnostics and therapies.”

About Viratech Corp.

Based in Stockton, California, Viratech Corp. has created an open source biotech research and development platform, Viratech has created a unique platform leveraging the utility of social collaboration, which will allow cancer research the opportunity for the first time to become open sourced.  This is accomplished by allowing our development partners the ability to protect, promote and produce their research in unified online collaboration hubs known as micro social networks. Viratech’s open source platform has integrated several intellectual property tools which, by leveraging our social collaboration network, can give our development partners a new intellectual property mechanism, which will help in addressing the protection of Intellectual Property, promotion through collaboration in our protected open source platform, and commercial development of the products achieved through collaborative research.

Using this platform, Viratech members can protect their intellectual property, then use Viratech’s micro social network as a utility to promote and crowdfund the research and development to produce the new technology.

Forward-Looking Statements:

This press release includes forward-looking statements concerning the future performance of our business, its operations and its financial performance and condition, and also includes selected operating results presented without the context of accompanying financial results. These forward-looking statements include, among others, statements with respect to our objectives and strategies to achieve those objectives, as well as statements with respect to our beliefs, plans, expectations, anticipations, estimates or intentions. These forward-looking statements are based on our current expectations. We caution that all forward-looking information is inherently uncertain and actual results may differ materially from the assumptions, estimates or expectations reflected or contained in the forward-looking information, and that actual future performance will be affected by a number of factors, including economic conditions, technological change, regulatory change and competitive factors, many of which are beyond our control. Therefore, future events and results may vary significantly from what we currently foresee. We are under no obligation (and we expressly disclaim any such obligation) to update or alter the forward-looking statements whether as a result of new information, future events or otherwise.

Contact : Dr. Kevin Buckman, CEO

Viratech Corp.

http://www.viratech.org

Email Contact: info@viratech.org

Newswire.net  – Los Angeles, CA, December 3, 2012-Well known fitness marketing expert Bedros Keuilian from PTpower.com has recently launched several new videos on how to run a successful fitness franchise.  Specifically in a new video by Bedros he speaks about the Fit Body Boot Camp Franchise Success Pillars.  Fit Body Boot Camp is a unique franchise model that focuses on 5 pillars.  In the video Bedros describes these pillars as the 4 S's.  The 4 S's consist of support, systems, sales funnel, and service.  Each one of these pillars is furthur broken down in greater detail for members of the Fit Body Boot Camp franchise.

This video has rapidly grown in popularity because these success pillars can be applied to any personal training or fitness boot camp business and many trainers are finding this video and sharing it with their colleagues.  Currently the video has reached over 1,300 views with more and more people from the fitness industry finding it each day.

About Bedros Keuilian

Bedros Keuilian is a fitness marketing expert who has helped thousands of personal trainers around the world with their personal training and fitness boot camp businesses.  Bedros and PTpower is hosting the 13th annual Fitness Business Summit in March.  For current events in the personal training and fitness business follow Bedros Keuilian on Twitter.

Newswire.net – Boston, December 3, 2012- Front line leaders are your change leaders. They implement new programs, new actions, and process improvements. They are what make everyone in your organization buy into your vision and mission. Managing change, and knowing how to do it, is a skill they must have.

The front line leadership transition training course gives your front line leaders the ability to identify and utilize skill sets that manage change, motivate their team and meet your organization’s objectives. Through identifying what makes a good leader and a bad leader, and reflecting on their own skill sets to discover their strengths and weaknesses, they start to see what impact change has on them, and how to acclimate themselves. Then they take those insights one step further, applying the process to each member of their team, and through that exercise, learn how to present change, entire buy-in from each individual and direct the team towards the desired result.

Along the way, they learn the five key leadership practices, how to build strategic relationships throughout the organization and how to create an engaging environment for their direct reports. The goal is for them to learn how to maximize their impact on the organization through teamwork, not sole performance.

A Transition Action Plan, customized to each participant, gives them a road map to immediately implementing their new skills to the betterment of your organization. The Transition Action Plan is created throughout the course by means of exercises. In each exercise, the participant learns something about his- or herself, notes it on the plan, and then puts together a comprehensive course of action based on those results. The Transition Action Plan is shared with their manager during a post-workshop discussion. The manager and participant use it to focus their efforts on certain areas as the participant becomes a leader in the organization.

Leading is not always just by example. It requires an understanding of the behaviors that successful leaders use to obtain results. The front line leadership transition training course not only provides that understanding, but also provides the tools to use it in a way that makes your organization stronger.

The Emerge Group, Inc. offers Front Line Leader Transition Training to its clients.  Emerge was founded by partners Sheldon Loar, and Jim Wentworth.  Free webinar training is offered each month.  For a schedule of upcoming events follow this link:  Front Line Leader Transition Training Course.

More in depth training is available on an individualized, or Company wide basis to meet your needs.  Contact Jim Wentworth  978-640-0906 to arrange a free consultation.

Newswire.net, Boston, MA, December 4, 2012 --A management pipeline training course provides managers in your organization the skills needed to recognize, develop and retain talent that is vital to continued success. It is a way to implement an inclusive strategy where recruitment, assessment, training and development, retention and leadership programs align with the organization's business objectives.

The management pipeline training course focuses on developing managers of managers. Their role in the organization is to cope with complexity of long term goals and focus on the systems and structure necessary to attain those directives. A key component in that is the talent in your organization. Given the costs of attracting and training new talent, developing it in-house saves money and creates consistency in the organization’s culture.

In the management pipeline training course, managers learn five critical advanced leadership accountabilities:

1. Selecting first-line leaders. Managers need to know how to avoid hiring clones, how to conduct a behavioral interview and the benefits of hiring outside and inside.


2. Developing first-line leaders. Managers need to identify the obstacles that may prevent leadership growth, know how to delegate and assign leadership work, hold leaders accountable, and reward great work. They need to assist first line leaders in empowering their direct reports, assign jobs that stretch talents to challenge them, and coach them effectively.


3. Fostering a strategic mindset. This process requires networking, building relationships and creating a culture of innovation and creativity. Managers are made to understand that risk taking is not frowned upon and can play an active part in strategic improvising planning.


4. Managing, dividing and reallocating resources. Resource deploying can be a scary thing for a new manager. Learning how to do it effectively in the areas of finance, technology and support staff will ensure your organization is in good hands.


5. Managing Boundaries. It is important that managers set clear expectations, lanes of responsibility and how individuals will be held accountable for their actions. It requires that the individual change from a functional to egalitarian viewpoint. Managers must make decisions for the good of the organization, not the individual.

At the end of the management pipeline training course, managers will leave with a 100 day action plan to implement their new ideas, skills and courses of action developed through exercises and reflection.

The Emerge Group, Inc. offers Management Pipeline Training to its clients.  Emerge was founded by partners Sheldon Loar, and Jim Wentworth.  Free webinar training is offered each month.  For a schedule of upcoming events follow this link:  Management Pipeline Training Course.

More in depth training is available on an individualized, or Company wide basis to meet your needs.  Contact Jim Wentworth  978-640-0906 to arrange a free consultation.

Tuesday, December 4, 2012

VANCOUVER, BC (NEWSWIRE)

Over the previous six months, the Greater Vancouver housing market has seen a decrease in the number of homes listed for sale, a gradual moderation in house prices and a decline in property sales when compared with historical averages.

The Real Estate Board of Greater Vancouver (REBGV) reports that residential property sales of detached, attached and apartment properties reached 1,686 on the area's Multiple Listing Service (MLS) in November, a 28.6 per cent decline compared to the 2,360 sales in November 2011 and a 12.7 per cent decline compared to the 1,931 house sales in October 2012.

November sales were 30.3 per cent below the 10-year November sales average of 2,420. "Home sellers appear more inclined to remove their properties from the market today rather than lower prices to sell their properties. On the other hand, buyers appear to be expecting prices to moderate," Eugen Klein, REBGV president said. New listings for detached, attached and apartment properties in Greater Vancouver totalled 2, 758 in November.

This represents a 14.4 per cent decline compared to November 2011 when 3,222 properties were listed for sale on the MLS and a 36.2 per cent decline compared to the 4,323 new listings in October 2012. New listings were 12.9 per cent below the 10-year November average of 3,168.

At 15,689, the sum total number of residential property listings on the MLS increased 13 per cent from this time a year ago and declined 9.7 per cent compared to October 2012. Total listings in the area have declined by not quite 3,000 properties since reaching a peak of 18,493 in June. The area's sales-to-active-listings ratio was unchanged from October at 11 per cent. "Home costs in Greater Vancouver have generally declined between three and five and a half per cent, according to property type, since reaching a peak six months ago," Klein said. "Changes in house prices vary per municipality and neighbourhood. It really is good to check local market statistics together with your REALTOR."

Since reaching a peak in May of $625,100, the MLS Dwelling Price Index composite standard price for many residential properties in Greater Vancouver has declined 4.5 per cent to $596,900. This represents a 1.7 per cent decrease when we compared to this time a year ago. Sales of detached properties in Greater Vancouver reached 629 in November, a decrease of 31.3 per cent from the 916 detached sales recorded in November 2011, and a 40.1 per cent decrease from the 1,050 units sold in November 2010. Since reaching a peak in May, the standard price for a detached property in Greater Vancouver has declined 5.5 per cent to $914,500.

Sales of apartment properties reached 750 in November 2012, a 25 per cent decrease compared to the 1,000 sales in November 2011, and a decrease of 28.7 per cent compared to the 1,052 sales in November 2010. Since reaching a peak in May, the standard price for an apartment property in Greater Vancouver has declined 3.9 per cent to $364,900. Attached property sales in November 2012 totalled 307, a 30.9 per cent decrease compared to the 444 sales in November 2011, and a 24.6 per cent decrease from the 407 attached properties sold in November 2010. Since reaching a peak in April, the standard

The Real Estate Board of Greater Vancouver is a self governing organization and looks at statistics daily.
http://www.rebgv.org
Real Estate Board of Greater Vancouver
2433 Spruce Street
Vancouver, BC
V6H 4C8

Tuesday, December 4, 2012

VANCOUVER (NEWSWIRE)

REBGV November sales were 30.3 per cent below the 10-year November sales average of 2,420.

“Home sellers appear more inclined to remove their properties from the market today rather than lower prices to sell their properties. On the other hand, buyers appear to be expecting prices to moderate,” Eugen Klein, REBGV president said.

New listings for detached, attached and apartment properties in Greater Vancouver (See all Vancouver homes here: http://www.realestatevancouver2010.com/homes/vancouver-west-homes/) totalled 2,758 in November. This represents a 14.4 per cent decline compared to November 2011 when 3,222 properties were listed for sale on the MLS® and a 36.2 per cent decline compared to the 4,323 new listings in October 2012.

New listings were 12.9 per cent below the 10-year November average of 3,168.

At 15,689, the total number of residential property listings on the MLS® increased 13 per cent from this time last year and declined 9.7 per cent compared to October 2012. Total listings in the region have declined by nearly 3,000 properties since reaching a peak of 18,493 in June.

The region’s sales-to-active-listings ratio was unchanged from October at 11 per cent.

“Home prices in Greater Vancouver have generally declined between three and five and a half per cent, depending on property type, since reaching a peak six months ago,” Klein said. “Changes in home prices vary per municipality and neighbourhood. It’s good to check local market statistics with your REALTOR®.”

Since reaching a peak in May of $625,100, the MLS® Home Price Index composite benchmark price for all residential properties in Greater Vancouver has declined 4.5 per cent to $596,900. This represents a 1.7 per cent decline when we compared to this time last year. For Vancouver condo properties the situation is even worse (see all Vancouver condos here: http://www.realestatevancouver2010.com/homes/vancouver-west-condos/)

Sales of detached properties in Greater Vancouver reached 629 in November, a decrease of 31.3 per cent from the 916 detached sales recorded in November 2011, and a 40.1 per cent decrease from the 1,050 units sold in November 2010. Since reaching a peak in May, the benchmark price for a detached property in Greater Vancouver has declined 5.5 per cent to $914,500.

Sales of apartment properties reached 750 in November 2012, a 25 per cent decrease compared to the 1,000 sales in November 2011, and a decrease of 28.7 per cent compared to the 1,052 sales in November 2010. Since reaching a peak in May, the benchmark price for an apartment property in Greater Vancouver has declined 3.9 per cent to $364,900.

Attached property sales in November 2012 totalled 307, a 30.9 per cent decrease compared to the 444 sales in November 2011, and a 24.6 per cent decrease from the 407 attached properties sold in November 2010. Since reaching a peak in April, the benchmark price for an attached property in Greater Vancouver has declined 3.6 per cent to $454,300.

Feature Facts:
  • Of the 15,689 homes currently for sale on the MLS® in Greater Vancouver, 49.6 per cent are listed for $600,000 or less. Of those, 1,321 are detached properties, 5,039 are condominiums and 1,419 are townhomes.
  • Of the 1,686 homes that sold in Greater Vancouver in November, 273 (16%) sold for $1 million or more.

November 2012 Statistics Package

The real estate industry is a key economic driver in British Columbia. In 2011, 32,390 homes changed ownership in the Board's area, generating $1.36 billion in spin-off activity and 9,069 jobs. The total dollar value of residential sales transacted through the MLS® system in Greater Vancouver totalled $25 billion in 2011. The Real Estate Board of Greater Vancouver is an association representing more than 11,000 REALTORS® and their companies. The Board provides a variety of member services, including the Multiple Listing Service®. For more information on real estate, statistics, and buying or selling a home, contact a local REALTOR® or visit www.rebgv.org.

For more information contact:

Craig Munn
Assistant Manager, Communication
Real Estate Board of Greater Vancouver
604-730-3146
cmunn@rebgv.org

STOCKTON, CALIFORNIA/December 5, 2012 / Newswire/ -- Viratech Corp. (OTC: VIRA), the first open source biotech research social network platform, announced today that it has entered into a Literary License Agreement with Dr. Harvey Gilbert, MD, to convert his book  Healthy Living: All in 1 Guide to Healthy Choices into a open source  body of knowledge (BOK).

Dr. Gilbert’s book has already touched the lives of many and, through this forum, those individuals can share their experiences and knowledge through Micro Social Networks, or MSNs. Each chapter will be its own MSN, allowing contributors to join as members and discuss each issue. By utilizing this innovative platform, the linear contents of the book will transform into a dynamic BOK, increasing the  knowledge, indexing the experiences and customizing the understanding of its contents. The BOK acts as a beacon of hope and knowledge for its participants and contributors through shared experiences, research and information

Dr. Gilbert stated, “I am excited to be the first author to have a book converted using Viratech’s new open source technology.  This allows my book to be a living body of knowledge that can be expanded upon, not just live on the shelves of a library, and to reach more people who can benefit from it.”

Dr. Gilbert is Board Certified with the American Board of Radiology and a specialist in Radiation Oncology. He is the founder and Director of the Ben Schaffer Cancer Institute, and is the past Medical Director of Oncure with over 100 cancer centers in the United States. He has written textbooks in the field of cancer and metastasis, and has also edited or written over 40 medical articles and is a speaker on topics in Oncology.

Dr. Gilbert has delivered over 40 medical presentations. His teaching appointments include the City of Hope Radiation Oncology, assistant Clinical Professor, UCLA Center of Health Services, and Department of Radiation Oncology. He has also been an Instructor of Family Practice at the Presbyterian Intercommunity Hospital in Whittier, CA.

Dr. Gilbert is the Medical Director of the Valley PET Institute and Founder and Director of the Lodi Integrative Wellness Center. He assisted in the founding of the first Inpatient Hospice in California while at Kaiser Hospital in Los Angeles, CA.

He co-authored some 40 articles in the medical literature and edited 13 texts in the Oncology Literature. His military services include serving as a Lieutenant in the US Navy.

 About Viratech Corp.

Based in Stockton, California, Viratech Corp. has created an open source biotech research and development platform. Viratech’s creation isa unique platform leveraging the utility of social collaboration, allowing,for the first time, the opportunity for biotech  research to become open sourced.  This is accomplished by allowing our development partners the ability to protect, promote and produce their research in unified online collaboration hubs known as micro social networks. Viratech’s open source platform has integrated several intellectual property tools which, by leveraging our social collaboration network, can give our development partners a new intellectual property mechanism, which will help in addressing the protection of Intellectual Property, promotion through collaboration in our protected open source platform, and commercial development of the products achieved through collaborative research.

Using this platform, Viratech members can protect their intellectual property, then use Viratech’s micro social network as a utility to promote and crowdfund the research and development to produce the new technology.

Forward-Looking Statements:

This press release includes forward-looking statements concerning the future performance of our business, its operations and its financial performance and condition, and also includes selected operating results presented without the context of accompanying financial results. These forward-looking statements include, among others, statements with respect to our objectives and strategies to achieve those objectives, as well as statements with respect to our beliefs, plans, expectations, anticipations, estimates or intentions. These forward-looking statements are based on our current expectations. We caution that all forward-looking information is inherently uncertain and actual results may differ materially from the assumptions, estimates or expectations reflected or contained in the forward-looking information, and that actual future performance will be affected by a number of factors, including economic conditions, technological change, regulatory change and competitive factors, many of which are beyond our control. Therefore, future events and results may vary significantly from what we currently foresee. We are under no obligation (and we expressly disclaim any such obligation) to update or alter the forward-looking statements whether as a result of new information, future events or otherwise.

Contact : Dr. Kevin Buckman, CEO/Director

Viratech Corp.

http://viratech.org

Email Contact: info@viratech.org

(Newswire.net) – Boston, December 5, 2012- First line manager transition training gives experienced first and front line leaders the perspective needed to meet the expectations that go with management responsibilities.  There is a certain attitude shift that accompanies such a change.

While a leader copes with change, a manager copes with complexity. A manager balances all the balls in the air that ultimately drive the change.

A leader works with the status quo, while a manager challenges the status quo to find what will improve the organization.

A leader asks what, but a manager asks why. Why does the organization need this, or do this?

A leader plans for the short term, and take the steps necessary to meet those goals. A manager plans for the long term, and sets the short term goals for which the leader plans to meet.

A leader organizes people and sets them to task; a manager aligns those people and resources so they available for the leader.

A leader motivates and inspires their team to accomplish great and wonderful things. They bring out the best to meet the organization’s goals. A manager administrates and controls those procedures and assets necessary to accompany the leader’s efforts.

A leader focuses on people. He or she know what drives their individual team members to succeed and meet expectations, and actively manipulates those drivers to optimize their team’s performance. A manager focuses on the systems and structures that enable their leaders. Those systems and structures provide the framework of the organization’s mission.

A leader follows the vision, and helps his or her team follow the vision. A manager communicates that vision to the leader and the staff, and delivers the support to meet it.

A leader works in the present, focusing on getting done what needs done in the most efficient and effective way. A manager looks into the future and provides the next goal for the leader to plan for, implement and attain.

First line manager transition training teaches new managers the skill sets, behavior changes and approaches to act in accordance with their new responsibilities.

The Emerge Group, Inc. offers First Line Manager Transition Training to its clients.  Emerge was founded by partners Sheldon Loar, and Jim Wentworth.  Free webinar training is offered each month.  For a schedule of upcoming events follow this link:  First Line Manager Transition Training Course.

More in depth training is available on an individualized, or Company wide basis to meet your needs.  Contact Jim Wentworth  978-640-0906 to arrange a free consultation.

(Newswire.net) – Boston, December 5, 2012-Extracts from green coffee bean can revolutionize the health and fitness market in the days to come. According to a recently published article in Dietrecommendations.com, the success of the popular weight loss program Green Coffee Bean Max can be attributed completely to the fat loss benefits of this latest breakthrough in weight loss fraternity. Dietrecommendations.com is a website that regularly publishes advice on health supplements, nutrition, and exercise. The green coffee bean extract reviews in this website informs that Green Coffee Bean Max exercise and diet program perfectly utilizes the fat burning power of green coffee beans to produce quick results.

Green coffee beans are nothing but coffee beans before they are roasted. Dietrecommendations.com informs that these green beans are roasted at 475 degrees Fahrenheit, resulting in its dark brown color. Chlorogenic Acid is the magic ingredient present in green coffee beans that is responsible for its fat burning and anti-oxidant properties. However, according to Dietrecommendations.com, 90% of these health benefits are lost when they are roasted. The article also informs that out of many green coffee bean diet programs available in the market, Green Coffee Bean Max is recommendable because it is effective, safe, and does not contain any artificial additives.

In a recent study conducted by American Chemical Society, it has been observed that green coffee bean extract can cause an average weight loss of 17.5 pounds over a period of 22 weeks. Dietrecommendations.com also informs that each buyer of Green Coffee Bean Max program receives free access to an online fitness program.  On select packages, they may also receive a free bottle of this green coffee bean capsules.

Anyone wishing to try Green Coffee Bean Max may do so here http://greencoffeebeanextractmax.com

The website also offers testimonials from different members of this program. Sara, one of the many highly satisfied members of Green Coffee Bean Max, strongly recommends the diet plan saying, "In just 30 days I lost weight and feel great. I am no longer embarrassed to wear a bikini, and my skin feels beautiful. Thank you so much for changing my life with this wonderful product".

About Dietrecommendations.com: Dietrecommendations.com is a closely followed health and fitness website offering regular advice on nutrition, health supplements, and workouts.  They are also affiliated with the website ProgradeSupplementReviews.com which has articles and reviews on Prograde Nutrition health supplements.

FOR IMMEDIATE RELEASE (NEWSWIRE.NET via EMAILNEWSWIRE.NET) DECEMBER 3RD, 2012 Zeeland, MI - Garden Crossings,  family-owned online retailer of plants and flowers, is now offering a selection of edible plants that can be eaten or used for seasoning and cooking. Plants like shade perennials are ideal for growing as an alternative food source in even the smallest or most urban spaces.

Garden Crossings’ wide selection of flowers, plants, vegetables and fruits can be used to start an urban garden that will produce a harvest within weeks. People who are concerned about the rising cost and sinking quality of produce at the grocery store, the use of pesticides in grocery store fruit, or who just want to get back to nature are encouraged to try growing natural products on their balconies, patios, terraces, or other spaces where natural light is available.

While many people grow their own fruits and vegetables in a backyard garden, urban agriculture is become more popular even among those without significant garden space. In some urban areas in places like Washington D.C. and Detroit, Michigan, “food deserts” exist, where access to and selection of fresh fruits, vegetables, roots, and herbs can be very limited because there might not be nearby supermarkets. Those urban dwellers desiring to experiment with new plants and roots can therefore have a very hard time finding those items.

Luckily, solutions are emerging for these problems. More people in cities maintain rooftop gardens or participate in community gardens.   Fruits, vegetables, and herbs can be grown in very limited spaces. Even flowers can be edible and delicious. Shade perennials like yarrow, otherwise known as achillea, can be eaten in salad, steeped to make tea, or sautéed. Hosta plants, or plantain lilies, are another example of edible plants that need minimal space to flourish. They can be prepared to eat in any number of ways, like any other vegetable.

Garden Crossings has focused its business on edible plants increasingly in recent years, as produce prices have spiked and people’s paychecks have stagnated.

“Gardening brought our family together, and part of the reason we continue to work in this business is because we get to spread the love of gardening. Growing plants and vegetables as a food source not only saves you money, it can help people living stressful urban lives to relax and feel in touch with nature. People who are interested in growing their own food can start small, with one plant, and get more as they feel more comfortable,” said Heidi Grasman, co-owner of Garden Crossings.  

New gardeners can use the planning tools listed on the Garden Crossings site, like the USDA Hardiness Map, to help them choose plants for their climate.  Plants are also listed on the Garden Crossings site by their most useful properties; for example, a given plant might be billed as attracting butterflies or resistant to rabbits. Garden Crossings ships two different sizes of plants all across the US.  

About Garden Crossings:

Launched in 2002, Garden Crossings is a family owned and operated garden center, offering the newest varieties of plants and flowers sometimes as early as one year before other stores. Based in Michigan, Garden Crossings has come to be known not only for its wide selection, but for its exceptional customer service.

Garden Crossings L.L.C.

Phone: 616-875-6355
Fax: 1-616-875-8765
Email us at: sales@gardencrossings.com

Rod Grasman: Co-Owner and Press Contact

(Newswire.net via Emailnewswire.com 11/29/2012) San Diego, CA In today’s market, many busy business owners are reluctant to spend money on corporate travel. However, business travel can mean big business for many customers looking to expand their client base. If a business meeting isn’t handled appropriately, it can quickly become unproductive. To ensure your business meeting planning is handled appropriately, customers look to POTHOS to provide meeting planning that produces favorable results.

Unlike other meeting planning companies, POTHOS provides businesses with distinct advantages. With certified and globally recognized meeting, conference, and event management services, POTHOS offers customers the benefit of their many years of experience. Through strategic business meeting planning services, POTHOS works with executive management to identify, plan, and achieve business objectives.

With a professional staff holding the highest certifications in business meeting planning and event management, the staff at POTHOS is dedicated to staying on top of current market trends to provide even more specialized service to its large client base. As a comprehensive meeting planning company, POTHOS is affiliated with Meetings Professional International (MPI). MPI is the largest association for the global meetings industry, and POTHOS’s affiliation allows them to enjoy access to a dynamic network of products and services.

POTHOS utilizes advanced enterprise solutions for procurement, data management, tracking, reporting, and cost savings solutions.  Since the company’s inception, POTHOS has managed thousands of successful business meetings, networking events, corporate travel arrangements, new product launches, and trade shows.

In addition to providing proven meeting planning solutions, POTHOS offers a corporate event planning division.  Every event reflects the mission of their clients clearly in a professional way. Experience with Fortune 500 clients, privately held businesses, and government clients allows POTHOS to produce a wide range of corporate grand openings, trade shows, new product launches, company parties and events.

All business professionals have attended meetings that they have enjoyed and those that weren’t as memorable. For companies looking to establish a reputation of providing engaging and informative business meetings, POTHOS can be the answer they need.

About Us:

POTHOS offers customers a team of dedicated event managers that help a variety of businesses across the country find solutions for their business meeting planning needs. Whether a business is hosting a corporate luncheon or a trade show for hundreds of participants, this experienced business meeting planning company is always ready to offer expert assistance.